Meisler Miriam H, Kearney Jennifer A, Sprunger Leslie K, MacDonald Bryan T, Buchner David A, Escayg Andrew
Department of Human Genetics, University of Michigan, Ann Arbor, 48109-0618, USA.
Novartis Found Symp. 2002;241:72-81; discussion 82-6, 226-32.
Spontaneous and induced mutations of neuronal Na+ channels in human patients and mutant mice result in a broad range of neurological-disease. Epilepsy, a disorder of neuronal hyperexcitability, has been associated with delayed inactivation of SCN2A in mice, and with altered kinetics of SCN1A in human patients. Movement disorders including tremor, ataxia, dystonia and paralysis have been observed in mice with mutations of SCN8A. Electrophysiological recordings from neurons isolated from mice with mutations in individual channels reveal the contributions of each channel to in vivo firing patterns. In addition to monogenic disease, Na+ channel mutations are likely to contribute to polygenic disease susceptibility and to normal variation in neuronal function. Advances in molecular methods coupled with genomic sequences from the Human Genome Project will permit identification of many new patient mutations and generation of animal models to dissect their physiological and cellular consequences.
人类患者和突变小鼠中神经元钠离子通道的自发突变和诱导突变会导致多种神经系统疾病。癫痫是一种神经元过度兴奋的疾病,与小鼠中SCN2A的失活延迟以及人类患者中SCN1A的动力学改变有关。在SCN8A发生突变的小鼠中观察到了包括震颤、共济失调、肌张力障碍和麻痹在内的运动障碍。从单个通道发生突变的小鼠中分离出的神经元进行的电生理记录揭示了每个通道对体内放电模式的作用。除了单基因疾病外,钠离子通道突变可能还会导致多基因疾病易感性以及神经元功能的正常变异。分子方法的进展以及来自人类基因组计划的基因组序列将有助于识别许多新的患者突变,并生成动物模型来剖析其生理和细胞后果。